The FDA announced on 2018-12-13 that Elekta, Inc. is recalling its MOSAIQ Oncology Information System and Sequencer because Wedge IDs may be omitted from DICOM RT PLAN files, causing incorrect radiation doses. GovInfoNow's records show the recall involves 3,950 units total.
How to tell if you have it
- Brand: Elekta
- Product: MOSAIQ Oncology Information System and Sequencer
- Versions: MOSAIQ Radiation Oncology version 1.0 and higher; Multi-ACCESS version 6.1 and higher
- UDIs: 858164002084, 858164002091, 858164002107, 858164002220, 858164002237
- Quantity: 3,950 units total (1,747 US)
- Distribution: U.S. Nationwide including AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY, District of Columbia, and Puerto Rico
The hazard
According to the FDA, Wedge IDs may not be included in the DICOM RT PLAN sent from the Treatment Planning System (TPS). This omission causes the field in MOSAIQ to be created without a wedge, resulting in the treatment receiving more dose than indicated in the plan.
Context
GovInfoNow's records show Elekta, Inc. has 39 other recalls on record since 2017-06-19. Other recent recalls of similar products include Elekta MOSAIQ Oncology System Software Recall (2026-05-21), Elekta Advanced Gynecological Applicator Recall (2026-04-03), and Elekta Leksell Vantage Arc System Recall (2026-03-19). Other recent recalls of similar products include RayStation/RayStation Software 11A Recalls (2025-11-28), RayStation/RayPlan 10B Software Recall (2025-11-28), and RayStation/RayPlan Software Recall (2025-11-28).